- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
Faron Pharmaceuticals Oy (DI) (FARN)
142.50p
- Change Today: -5.00p
- 52 Week High: 350.00p
- 52 Week Low: 92.50p
- Currency: UK Pounds
- Shares Issued: 104.62m
- Volume: 6,706
- Market Cap: £149.09m
- Beta: 1.67
Trade now with Barclays Stockbrokers
Update - 
Latest ShareCast News
Faron Pharmaceuticals files new patent for Clever-1
By Josh White
Date: Monday 11 Nov 2024
(Sharecast News) - Faron Pharmaceuticals, a clinical-stage biopharmaceutical company specialising in immunotherapies for cancer and inflammatory diseases, announced the filing of a new patent application for the use of soluble Clever-1 in targeting T-cell inactivation on Monday, with potential applications in treating autoimmune diseases and inflammatory disorders.
Faron Pharmaceuticals candidate gets FDA fast track designation
By Josh White
Date: Tuesday 27 Aug 2024
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Tuesday that its lead candidate, bexmarilimab, has been granted fast track designation by the US Food and Drug Administration (FDA), for the treatment of relapsed or refractory myelodysplastic syndrome (r/r MDS) in combination with azacitidine.
Faron gets positive FDA feedback on bexmarilimab study plans
By Josh White
Date: Thursday 11 Jul 2024
(Sharecast News) - Faron Pharmaceuticals announced positive feedback from the FDA regarding the clinical development plan for its drug candidate bexmarilimab, aimed at treating myelodysplastic syndrome (MDS), on Thursday.
FARN Market Data
| Currency | UK Pounds |
| Share Price | 142.50p |
| Change Today | -5.00p |
| % Change | -3.39 % |
| 52 Week High | 350.00p |
| 52 Week Low | 92.50p |
| Volume | 6,706 |
| Shares Issued | 104.62m |
| Market Cap | £149.09m |
| Beta | 1.67 |
FARN Star Ratings
| Value |
     |
|---|
| Price Trend |
|
|---|
| Income |  |
|---|
| Growth | |
|---|
What The Brokers Say
| Strong Buy | 1 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 3 |
FARN Dividends
| No dividends found |
Trades for 21-Nov-2024
| Time | Volume / Share Price |
| 16:04 | 1,000 @ 143.50p |
| 15:48 | 130 @ 140.00p |
| 15:39 | 340 @ 143.50p |
| 15:38 | 688 @ 143.50p |
| 15:26 | 1,550 @ 144.50p |
FARN Key Personnel
| CFO | Yrjö E K Wichmann |
| CEO | Juho Jalkanen |
| Chair | Tuomo Pätsi |
You are here: research
10 Lower Thames St,
London EC3R 6EN